These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 19666163)

  • 1. The necessity of accurate costs.
    Hankins S
    Am J Prev Med; 2009 Sep; 37(3):258-9. PubMed ID: 19666163
    [No Abstract]   [Full Text] [Related]  

  • 2. Cost effectiveness in context.
    Schechter CB
    J Clin Oncol; 2007 Feb; 25(6):609-10. PubMed ID: 17308263
    [No Abstract]   [Full Text] [Related]  

  • 3. Distorted spending priorities in Canada.
    Tyers GF
    CMAJ; 2000 May; 162(10):1402, 1404. PubMed ID: 10834040
    [No Abstract]   [Full Text] [Related]  

  • 4. Using of osmotic fragility (OF) and dichlorophenol-indolephenol (DCIP) tests screening for antenatal clinic: appraisal of usefulness of the program in rural Thai communities.
    Wiwanitkit V
    Rural Remote Health; 2006; 6(2):587. PubMed ID: 16671839
    [No Abstract]   [Full Text] [Related]  

  • 5. Cost-effectiveness of endoscopic screening followed by surveillance for Barrett's esophagus: a review.
    Barbiere JM; Lyratzopoulos G
    Gastroenterology; 2009 Dec; 137(6):1869-76. PubMed ID: 19840798
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cost-effectiveness of genotyping in inherited arrhythmia syndromes: are we getting value for the money?
    Wilde AA; Pinto YM
    Circ Arrhythm Electrophysiol; 2009 Feb; 2(1):1-3. PubMed ID: 19808437
    [No Abstract]   [Full Text] [Related]  

  • 7. [Digestive diseases and health economics].
    Kobayashi Y
    Nihon Shokakibyo Gakkai Zasshi; 2001 Dec; 98(12):1335-40. PubMed ID: 11808098
    [No Abstract]   [Full Text] [Related]  

  • 8. Newborn screening: the spigot is open and threatens to become a flood.
    Cederbaum S
    J Pediatr; 2007 Aug; 151(2):108-10. PubMed ID: 17643755
    [No Abstract]   [Full Text] [Related]  

  • 9. More on 'universal'versus'selected' screening for thrombophilia: the hidden costs of false-positive diagnosis.
    Favaloro EJ
    Br J Haematol; 2006 Jul; 134(2):239-40; author reply 241. PubMed ID: 16846484
    [No Abstract]   [Full Text] [Related]  

  • 10. Search and destroy policy for methicillin-resistant Staphylococcus aureus: cost-benefit analysis.
    Simoens S; Ophals E; Schuermans A
    J Adv Nurs; 2009 Sep; 65(9):1853-9. PubMed ID: 19694848
    [TBL] [Abstract][Full Text] [Related]  

  • 11. What is the value of screening?
    Munro J
    Br J Hosp Med; 1996 Oct 16-Nov 5; 56(8):382, 384. PubMed ID: 8909709
    [No Abstract]   [Full Text] [Related]  

  • 12. [Economic assessment in health care: contribution and limits].
    Lanoë JL
    Gastroenterol Clin Biol; 1996 Feb; 20(1):33-5. PubMed ID: 8734309
    [No Abstract]   [Full Text] [Related]  

  • 13. What price to pay? The cost of everything and the value of nothing.
    Ezekowitz JA
    Circulation; 2009 Jan; 119(3):368-70. PubMed ID: 19171866
    [No Abstract]   [Full Text] [Related]  

  • 14. Stamping out disease.
    Meyer C
    Minn Med; 1996 Oct; 79(10):2. PubMed ID: 8937045
    [No Abstract]   [Full Text] [Related]  

  • 15. The medical arms race.
    Gordon J
    Minn Med; 2007 Feb; 90(2):26-9, 44. PubMed ID: 17388256
    [No Abstract]   [Full Text] [Related]  

  • 16. The harms of screening: new attention to an old concern.
    Woolf SH; Harris R
    JAMA; 2012 Feb; 307(6):565-6. PubMed ID: 22318274
    [No Abstract]   [Full Text] [Related]  

  • 17. Palliative care: no longer a luxury but a necessity?
    Higginson IJ; Foley KM
    J Pain Symptom Manage; 2009 Jul; 38(1):1-3. PubMed ID: 19615620
    [No Abstract]   [Full Text] [Related]  

  • 18. Is the National Child Measurement Programme a waste of money?
    Osborne J
    Community Pract; 2009 Apr; 82(4):42; discussion 42. PubMed ID: 19397085
    [No Abstract]   [Full Text] [Related]  

  • 19. Health screening services--ready for a "virtual" joyride?
    Tageja N
    Prev Med; 2010 Nov; 51(5):433. PubMed ID: 20691722
    [No Abstract]   [Full Text] [Related]  

  • 20. Economics of cancer screening: total costs and benefits in economic terms.
    Pedersen KM
    Eur J Cancer; 1994; 30A(6):879-84. PubMed ID: 7917552
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.